These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 22640807)

  • 1. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
    Maddur MS; Miossec P; Kaveri SV; Bayry J
    Am J Pathol; 2012 Jul; 181(1):8-18. PubMed ID: 22640807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Th17 cells in autoimmune diseases.
    Yang J; Sundrud MS; Skepner J; Yamagata T
    Trends Pharmacol Sci; 2014 Oct; 35(10):493-500. PubMed ID: 25131183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
    Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E
    Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
    Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
    Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IL-17 pathway as a major therapeutic target in autoimmune diseases.
    Hu Y; Shen F; Crellin NK; Ouyang W
    Ann N Y Acad Sci; 2011 Jan; 1217():60-76. PubMed ID: 21155836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of IL-17A in inflammatory immune responses and host defense against pathogens.
    Iwakura Y; Nakae S; Saijo S; Ishigame H
    Immunol Rev; 2008 Dec; 226():57-79. PubMed ID: 19161416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
    Wu D; Wang J; Pae M; Meydani SN
    Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
    Zhu S; Qian Y
    Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune inflammation from the Th17 perspective.
    Furuzawa-Carballeda J; Vargas-Rojas MI; Cabral AR
    Autoimmun Rev; 2007 Jan; 6(3):169-75. PubMed ID: 17289553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17 cells in autoimmune diseases.
    Han L; Yang J; Wang X; Li D; Lv L; Li B
    Front Med; 2015 Mar; 9(1):10-9. PubMed ID: 25652649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints.
    Miyamoto Y; Uga H; Tanaka S; Kadowaki M; Ikeda M; Saegusa J; Morinobu A; Kumagai S; Kurata H
    Mol Immunol; 2013 Jun; 54(2):199-207. PubMed ID: 23287598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells.
    Lexberg MH; Taubner A; Albrecht I; Lepenies I; Richter A; Kamradt T; Radbruch A; Chang HD
    Eur J Immunol; 2010 Nov; 40(11):3017-27. PubMed ID: 21061434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6-mediated Th17 differentiation through RORγt is essential for the initiation of experimental autoimmune myocarditis.
    Yamashita T; Iwakura T; Matsui K; Kawaguchi H; Obana M; Hayama A; Maeda M; Izumi Y; Komuro I; Ohsugi Y; Fujimoto M; Naka T; Kishimoto T; Nakayama H; Fujio Y
    Cardiovasc Res; 2011 Sep; 91(4):640-8. PubMed ID: 21622681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection.
    Akdis M; Palomares O; van de Veen W; van Splunter M; Akdis CA
    J Allergy Clin Immunol; 2012 Jun; 129(6):1438-49; quiz1450-1. PubMed ID: 22657405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-9 is a Th17-derived cytokine that limits pathogenic activity in organ-specific autoimmune disease.
    Stephens GL; Swerdlow B; Benjamin E; Coyle AJ; Humbles A; Kolbeck R; Fung M
    Eur J Immunol; 2011 Apr; 41(4):952-62. PubMed ID: 21360526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models.
    Wang X; Ma C; Wu J; Zhu J
    J Neurosci Res; 2013 Jul; 91(7):871-81. PubMed ID: 23653308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between Th17 cells and tumor microenvironment.
    Qi W; Huang X; Wang J
    Cell Immunol; 2013; 285(1-2):18-22. PubMed ID: 24044962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
    Prochazkova J; Pokorna K; Holan V
    Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A naturally occurring, soluble antagonist of human IL-23 inhibits the development and in vitro function of human Th17 cells.
    Yu RY; Gallagher G
    J Immunol; 2010 Dec; 185(12):7302-8. PubMed ID: 21076058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.
    Ivanov II; McKenzie BS; Zhou L; Tadokoro CE; Lepelley A; Lafaille JJ; Cua DJ; Littman DR
    Cell; 2006 Sep; 126(6):1121-33. PubMed ID: 16990136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.